SITUS JUDI MBL77 NO FURTHER A MYSTERY

Not all people with CLL call for therapy. Despite all recent advances, the iwCLL even now endorses watchful observation for people with asymptomatic disorder.86 This advice is based on at the very least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Each